Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP · 6 quarters on record
This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in ZENAS BIOPHARMA INC (ZBIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 83,353 | -13,312 | -13.8% | 1.62% | $3.0M | $36.31 |
| 2025 Q3 | REDUCED | 96,665 | -14,940 | -13.4% | 2.11% | $2.1M | $22.20 |
| 2025 Q2 | UNCHANGED | 111,605 | — | 0% | 1.28% | $1.1M | $9.69 |
| 2025 Q1 | UNCHANGED | 111,605 | — | 0% | 1.05% | $882K | $7.90 |
| 2024 Q4 | UNCHANGED | 111,605 | — | 0% | 0.79% | $914K | $8.19 |
| 2024 Q3 | INITIATED | 111,605 | — | — | 1.65% | $1.9M | $16.92 |
As of 2025 Q4 — sorted by position size